The global stem cell banking market was valued at $4,298.5 million in 2020, and is projected to reach $16,558.4 million by 2030, registering a CAGR of 15.6% from 2021 to 2030.
Stem cell banking is the process of procuring precious stem cells from human body, processing and storing them for potential future use in stem cell treatments. Stem cell banks use low temperatures to preserve the biological properties of stem cells, protect them from contamination and degeneration. Standardized and quality controlled preservative procedures are required for any stem cell bank in order to preserve the cells for longer periods of time without losing their properties.
Rise in number of births occurring globally, increase in R&D activities in regards with applications of stem cells, and surge in prevalence of fatal chronic diseases drive the growth of the market. In addition, stem cells are used for various types of cancers and blood related diseases. For instance, according to the Journal of Leukemia & lymphoma society’s report, in 2021, it was estimated that around 186,400 populations in the U.S. are diagnosed with leukemia, lymphoma, or myeloma. The rise in disposable income globally is projected to help increase the number of stem cell units stored, which in turn boosts the market growth.
Furthermore, surge in demand for advanced treatment for serious diseases boosts market growth. The rise in number of stem cell banks and increase in health expenditure of peoples further contribute in market growth.
The stem cell banking market is segmented on the basis of service type, utilization, cell type, bank type, and region. By service type, the market is mainly categorized into collection & transportation, processing, analysis, and storage. On the basis of utilization, it is categorized in used and unused. Depending on cell type, it is classified into umbilical cord stem cell, cord blood, cord tissue, placenta, adult stem cell, and embryonic stem cell. By bank type, the market is divided into public and private. By age group, the market is mainly categorized into adult and children. By Type, it is categorized in brackets, anchorage appliances, ligatures, and arch wires. By Region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include stem cell banking market American CryoStem Corporation, Americord Registry LLC, Cordlife Group Limited, Cordlife Group Limited, Cryoholdco De LatinoAmerica, S.A.P.I. DE C.V., StemCyte Cord Blood Bank, Covis Pharma., Global Cord Blood Corporation., Smart cells. and CSG BIO.
Stem cell banking is the process of procuring precious stem cells from human body, processing and storing them for potential future use in stem cell treatments. Stem cell banks use low temperatures to preserve the biological properties of stem cells, protect them from contamination and degeneration. Standardized and quality controlled preservative procedures are required for any stem cell bank in order to preserve the cells for longer periods of time without losing their properties.
Rise in number of births occurring globally, increase in R&D activities in regards with applications of stem cells, and surge in prevalence of fatal chronic diseases drive the growth of the market. In addition, stem cells are used for various types of cancers and blood related diseases. For instance, according to the Journal of Leukemia & lymphoma society’s report, in 2021, it was estimated that around 186,400 populations in the U.S. are diagnosed with leukemia, lymphoma, or myeloma. The rise in disposable income globally is projected to help increase the number of stem cell units stored, which in turn boosts the market growth.
Furthermore, surge in demand for advanced treatment for serious diseases boosts market growth. The rise in number of stem cell banks and increase in health expenditure of peoples further contribute in market growth.
The stem cell banking market is segmented on the basis of service type, utilization, cell type, bank type, and region. By service type, the market is mainly categorized into collection & transportation, processing, analysis, and storage. On the basis of utilization, it is categorized in used and unused. Depending on cell type, it is classified into umbilical cord stem cell, cord blood, cord tissue, placenta, adult stem cell, and embryonic stem cell. By bank type, the market is divided into public and private. By age group, the market is mainly categorized into adult and children. By Type, it is categorized in brackets, anchorage appliances, ligatures, and arch wires. By Region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include stem cell banking market American CryoStem Corporation, Americord Registry LLC, Cordlife Group Limited, Cordlife Group Limited, Cryoholdco De LatinoAmerica, S.A.P.I. DE C.V., StemCyte Cord Blood Bank, Covis Pharma., Global Cord Blood Corporation., Smart cells. and CSG BIO.
KEY BENEFITS FOR STAKEHOLDERS
- The report provides an in-depth analysis of the global stem cell banking market size along with the current trends and future estimations to elucidate the imminent investment pockets
- It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market
- A comprehensive analysis of the region assists to understand the regional market and facilitate strategic business planning and determine prevailing opportunities
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global stem cell banking market growth
KEY MARKET SEGMENTS
By Service Type
- Collection & Transportation
- Processing
- Analysis
- Storage
By Utilization
- Used
- Unused
By Cell Type
- Umbilical Cord Stem Cell
- Cord Blood
- Cord Tissue
- Placenta
- Adult Stem Cell
- Embryonic Stem Cell
By Bank Type
- Public
- Private
By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
KEY MARKET PLAYERS
- American CryoStem Corporation
- Americord Registry LLC
- Cordlife Group Limited
- Cryo Cell International Inc
- Cryoholdco De LatinoAmerica, S.A.P.I. DE CV
- StemCyte Cord Blood Bank
- Covis Pharma
- Global Cord Blood Corporation
- Smart cells
- CSG BIO
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
Chapter 1: Introduction
Chapter 2: Executive Summary
Chapter 3: Market Landscape
Chapter 4: Stem Cell Banking Market, by Service Type
Chapter 5: Stem Cell Banking Market, by Utilization
Chapter 6: Stem Cell Banking Market, by Cell Type
Chapter 7: Stem Cell Banking Market, by Bank Type
Chapter 8: Stem Cell Banking Market, by Region
Chapter 9: Company Profiles
List of Tables
List of Figures
Executive Summary
According to a new report titled, “Stem Cell Banking Market by Age Group and Type: Global Opportunity Analysis and Industry Forecast, 2021–2030, the global stem cell banking market size was valued at $4,298.5 million in 2020, and is projected to reach $16,558.4 million by 2030, registering a CAGR of 15.6% from 2021 to 2030.Stem cells are used to repair and self-renew damaged cells. It is also used to treat various medical conditions such as leukemia, lymphoma, neuroblastoma, and multiple myeloma. These cells are stored in stem cell banks, as they have the potential for usage in the treatment of any medical conditions. The collected stem cells are cryopreserved and stored for decades, which can be later used to treat large number of chronic diseases such as leukemia, thalassemia, and diabetes.
Factors that drive the growth of the stem cell banking market include the rise in number of stem cell banks and increase in prevalence of fatal disorders. In addition, rise in incidence of congenital diseases drives the growth of market. For instance, according to World Health Organization (WHO), in December 2020, it was reported that around 295,000 newborns die within 28 days of birth every year, worldwide due to congenital anomalies. Furthermore, increase in R&D activity in stem cell development and large number of clinical trials for stem cell application in various diseases contributes in the growth of the stem cell banking market.
The stem cell banking market is segmented on the basis of service type, utilization, cell type, bank type, and region.
On the basis of service type, the market is categorized into collection & transportation, processing, analysis, and storage. The storage segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to increase in number of stem cell banks.
By utilization, the market is divided into used and unused. The used segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to the increase in clinical trials for stem cell applications.
On the basis of cell type, the market is categorized into umbilical cord stem cell, cord blood, cord tissue, placenta, adult stem cell, and embryonic stem cell. The umbilical cord stem cell segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to the application to treat multiple medical conditions and can be easily collected without any risk for the mother and baby.
Depending on bank type, the market is divided into public and private. The public segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to low cost of stem cell therapy at public banks.
The COVID-19 outbreak is anticipated to have a negative impact on the growth of the stem cell banking market. The spread of COVID-19 led to a major public health issue. Most of the stem cell collection procedures were slowed down to avoid spread of COVID-19 virus. However, clinical trials for application of stem cells for COVID-19 treatment, may contribute to the market growth post pandemic.
Key Findings Of Study
- On the basis of service type, the storage segment was the highest contributor to the market in 2020
- Depending on utilization, the used segment was the highest contributor to the stem cell banking market in 2020
- Based on of cell type, the umbilical cord stem cell segment was the highest contributor to the market in 2020
- On the basis of bank type, the public segment was the highest contributor to the market in 2020
- On the basis of region, North America garnered the largest revenue share in 2020, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period
- North America garnered the major share in the stem cell banking Market in 2020, and is expected to dominate the global market during the forecast period, owing to rise in prevalence of chronic diseases, presence of key players for development of stem cells storage, and well-established healthcare infrastructure in the region. However, Asia-Pacific is expected to register the highest CAGR of 165% from 2021 to 2030, owing to increase in the number of hospitals, surge in demand for early diagnosis, rise in prevalence of cancer, cardiac disease, and growth in number of geriatric population
Companies Mentioned
- American CryoStem Corporation
- Americord Registry LLC
- Cordlife Group Limited
- Cordlife Group Limited
- Cryoholdco De LatinoAmerica
- S.A.P.I. DE C.V.
- StemCyte Cord Blood Bank
- Covis Pharma.
- Global Cord Blood Corporation.
- Smart cells.and CSG BIO.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 220 |
| Published | February 2022 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 3885.44 million |
| Forecasted Market Value ( USD | $ 16558.4 million |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
